1. Hypertonic saline and recombinant human DNase: a randomised cross-over pilot study in patients with cystic fibrosis 
Manfred Ballmann, Horst von der Hardt 
Journal of Cystic Fibrosis 
Volume 1, Issue 1, Pages (March 2002)
DOI: /S (01)

2. Fig. 1
Changes of FEV1(% predicted) from baseline are shown after 3 weeks treatment with HS (■) and with rhDNase (□) for each single patient. Patient no. 8 showed no change with HS.
Journal of Cystic Fibrosis 2002 1, 35-37DOI: ( /S (01) )